Attovia Therapeutics, Inc.

NASDAQ:ATTO

Biotechnology

Healthcare
$15.53 -1.20%

-$0.18 today

Market cap
$709.92M
Beta
0.00
P/E (TTM)
-15.9
EPS (TTM)
-$0.86
52W Low $14.23High $28.00

Volume 0.34M

Average 0.45M

Balance Sheet

Inspect the capital base behind the business.

Assets

$165.89M

FY 2025 · Annual

+116.2% YoY

Liabilities

$15.10M

FY 2025 · Annual

+3.5% YoY

Equity

$150.79M

FY 2025 · Annual

+142.7% YoY

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$32.8M
Short-term Investments$82.3M
Other Current$3.3M
Total Current Assets$118.4M
PP&E (Net)$6.9M
Long-term Investments$404.0K
Other Non-current$2.6M
Total Non-current Assets$9.9M
Total Assets$128.3M

Analysis

Selected assets total $128.3M for Latest. The largest visible component is Short-term Investments at $82.3M, about 64.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
SC 13GSC 13G filingNov 13, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
3/A3/A filingOct 8, 2026

How much cash does ATTO have?

Attovia Therapeutics, Inc. (ATTO) reported $40.19M in cash and equivalents in fiscal 2025.

How much debt does ATTO carry?

Attovia Therapeutics, Inc. (ATTO) reported $5.26M of total debt, with net debt of -$34.93M.